Serveur d'exploration Tocilizumab - Analysis (France)

Index « Mesh.i » - entrée « Severity of Illness Index »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serum Amyloid A Protein < Severity of Illness Index < Sex Factors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000089 (2019) Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000091 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000160 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
000178 (2018) P. Tétu [France] ; A. Hamelin [France] ; P. Moguelet [France] ; A. Barbaud [France] ; A. Soria [France]Management of hypersensitivity reactions to Tocilizumab.
000210 (2018) Pauline Baudart [France] ; Johann Cesini [France] ; Christian Marcelli [France]Atypical juxta-articular form of Dercum's disease in a patient treated with tocilizumab for rheumatoid arthritis.
000211 (2018) Valérie Devauchelle-Pensec [France] ; Lea Saraux [France] ; Jean Marie Berthelot [France] ; Michel De Bandt [France] ; Divi Cornec [France] ; Dewi Guellec [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
000235 (2017) Jean-Jacques Dubost [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Martin Soubrier [France]The changing face of septic arthritis complicating rheumatoid arthritis in the era of biotherapies. Retrospective single-center study over 35years.
000240 (2017) Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raim N Sanmarti [Espagne] ; Min Bao [États-Unis] ; Corrado Bernasconi [Suisse] ; Attila Pethö-Schramm [Suisse]Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
000244 (2017) Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Celia J F. Lin [États-Unis] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Janet E. Pope [Canada] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Helen Spotswood [Royaume-Uni] ; Laura Burke [Royaume-Uni] ; Jeffrey Siegel [États-Unis] ; Angelika Jahreis [États-Unis] ; Daniel E. Furst [États-Unis]Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
000272 (2017) Johanna Sigaux [France] ; Moustafa Hamze [France] ; Claire Daien [France] ; Jacques Morel [France] ; Roman Krzysiek [France] ; Marc Pallardy [France] ; Bernard Maillere [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France]Immunogenicity of tocilizumab in patients with rheumatoid arthritis.
000282 (2017) Guillermo Carvajal Alegria ; Valérie Devauchelle-Pensec ; Yves Renaudineau [France] ; Alain Saraux ; Jacques-Olivier Pers [France] ; Divi CornecCorrection of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.
000292 (2017) Marie Hugo [France] ; Audrey Pierreisnard [France] ; Nadia Mehsen-Cetre [France] ; Henri Gin [France] ; Thierry Schaeverbeke [France] ; Vincent Rigalleau [France]Action of tocilizumab on energy expenditure in rheumatoid arthritis: A prospective study using calorimetry and actimetry.
000305 (2016) Alban Deroux [France] ; Chistophe Chiquet [France] ; Laurence Bouillet [France]Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.
000319 (2016) Éric Toussirot [France] ; Antoine Martin [France] ; Martin Soubrier [France] ; Serge Redeker [France] ; Alexis Régent [France]Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
000321 (2016) P O Barros ; T. Cassano ; J. Hygino ; T B Ferreira ; N. Centurião ; T M Kasahara ; R M Andrade ; U C Linhares ; A F B. Andrade [Brésil] ; C C F. Vasconcelos ; R. Alvarenga ; R. Marignier [France] ; C A M. BentoPrediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
000338 (2016) Valérie Devauchelle-Pensec [France] ; Jean Marie Berthelot [France] ; Divi Cornec [France] ; Yves Renaudineau [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Solène Querellou [France] ; Florent Garrigues [France] ; Michel De Bandt [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
000339 (2016) Jessie Risse [France] ; Damien Mandry ; Nicla Settembre ; Charlène Vigouroux ; Marine Claudin ; Georgia Tsintzila ; Olivier Huttin ; Sergueï Malikov ; Stéphane Zuily ; Denis WahlDramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease.
000363 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000390 (2015) Marie Leroy [France] ; Guillaume Coiffier [France] ; Charlotte Pronier [France] ; Louise Triquet [France] ; Aleth Perdriger [France] ; Pascal Guggenbuhl [France]Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis.
000395 (2015) Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
000406 (2015) Gerd R. Burmester [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Alain Cantagrel [France] ; Stephen Hall [Australie] ; Piotr Leszczynski [Pologne] ; Daniel Feldman [Brésil] ; Madura J. Rangaraj [États-Unis] ; Georgia Roane [États-Unis] ; Charles Ludivico [États-Unis] ; Min Bao [États-Unis] ; Lucy Rowell [Royaume-Uni] ; Claire Davies [Royaume-Uni] ; Eduardo F. Mysler [Argentine]Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Mesh.i -k "Severity of Illness Index" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Mesh.i  \
                -Sk "Severity of Illness Index" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Severity of Illness Index
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021